These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10412001)

  • 1. Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium.
    Rochat B; Baumann P; Audus KL
    Brain Res; 1999 Jun; 831(1-2):229-36. PubMed ID: 10412001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats.
    Wikell C; Apelqvist G; Carlsson B; Hjorth S; Bergqvist PB; Kugelberg FC; Ahlner J; Bengtsson F
    Clin Neuropharmacol; 1999; 22(6):327-36. PubMed ID: 10626092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations.
    Kosel M; Gnerre C; Voirol P; Amey M; Rochat B; Bouras C; Testa B; Baumann P
    Mol Psychiatry; 2002; 7(2):181-8. PubMed ID: 11840311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.
    Rochat B; Kosel M; Boss G; Testa B; Gillet M; Baumann P
    Biochem Pharmacol; 1998 Jul; 56(1):15-23. PubMed ID: 9698084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotin uptake and transport across bovine brain microvessel endothelial cell monolayers.
    Shi F; Bailey C; Malick AW; Audus KL
    Pharm Res; 1993 Feb; 10(2):282-8. PubMed ID: 8456078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram.
    Aronson S; Delgado P
    Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.
    Baumann P; Zullino DF; Eap CB
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):433-44. PubMed ID: 12208561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.
    Bismuth-Evenzal Y; Roz N; Gurwitz D; Rehavi M
    Biochem Pharmacol; 2010 Nov; 80(10):1546-52. PubMed ID: 20696140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.
    Lundberg J; Christophersen JS; Petersen KB; Loft H; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):777-85. PubMed ID: 17201996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
    Owens JM; Knight DL; Nemeroff CB
    Encephale; 2002; 28(4):350-5. PubMed ID: 12232544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography.
    Kosel M; Eap CB; Amey M; Baumann P
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):234-8. PubMed ID: 9869386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic consequences of a citalopram treatment discontinuation.
    Voirol P; Rubin C; Bryois C; Kosel M; Buclin T; Baumann P
    Ther Drug Monit; 1999 Jun; 21(3):263-6. PubMed ID: 10365634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites.
    Unceta N; Goicolea MA; Barrio RJ
    Biomed Chromatogr; 2011 Jan; 25(1-2):238-57. PubMed ID: 21058412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice.
    Uhr M; Grauer MT
    J Psychiatr Res; 2003; 37(3):179-85. PubMed ID: 12650738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram.
    Burke WJ
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1477-86. PubMed ID: 12387707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of adverse interactions between concomitantly administered selegiline and citalopram.
    Laine K; Anttila M; Heinonen E; Helminen A; Huupponen R; Mäki-Ikola O; Reinikainen K; Scheinin M
    Clin Neuropharmacol; 1997 Oct; 20(5):419-33. PubMed ID: 9331518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.